{"id":13562,"date":"2022-11-03T10:10:31","date_gmt":"2022-11-03T09:10:31","guid":{"rendered":"https:\/\/www.mybits.de\/establishment-and-operation-of-a-european-trading-platform-for-pharmaceuticals\/"},"modified":"2025-03-18T14:54:16","modified_gmt":"2025-03-18T13:54:16","slug":"establishment-and-operation-of-a-european-trading-platform-for-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/www.mybits.de\/en\/establishment-and-operation-of-a-european-trading-platform-for-pharmaceuticals\/","title":{"rendered":"Establishment and operation of a European trading platform for pharmaceuticals<\/b>"},"content":{"rendered":"

Establishment and operation of a European trading platform for pharmaceuticals<\/strong><\/h1>\n<\/div>

Together with arex PHARMA GmbH<\/a>, a specialist in the international trade and distribution of European pharmaceuticals, BITS GmbH has established the EU-wide trading platform Rxchange<\/a> for pharmaceutical products as a strategic IT partner.<\/p>\n<\/div>

\"it<\/span><\/div>

The individually developed, Internet-based B2B platform enables all market participants to coordinate their buying and selling intentions for pharmaceutical and medical technology products among themselves within the European Union (EU) and to execute them through arex PHARMA as the central counterparty. In doing so, they are supported by numerous functions of the platform from the areas of order and offer management, product, portfolio and price management as well as logistics and warehouse management. In addition to interfaces to individual ERP systems (e.g. Business Central) and APIs (including for the individual national drug verification systems), mobile apps (including for goods scanning, put-to-light and pick-to-light activities) are also available.<\/p>\n

The tasks of BITS in this project mainly include tasks in IT consulting, IT architecture, IT project management and IT quality assurance.<\/p>\n<\/div>

<\/i><\/span><\/div>

27 EU Member States<\/h2><\/div>
<\/div>
\n

Web-based platform for trading within the European Union<\/p>\n<\/div><\/div><\/div>

<\/i><\/span><\/div>

100% workflow coverage<\/h2><\/div>
<\/div>
\n

Digital coverage of the entire retail workflow<\/p>\n<\/div><\/div><\/div>

<\/i><\/span><\/div>

360\u00b0 interfaces<\/h2><\/div>
<\/div>
\n

Numerous interfaces to legacy systems, ERPs and APIs<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div><\/div>

BITS as a strategic IT partner<\/h2>\n<\/div>
\n

“Together with BITS GmbH as a strategic IT partner, we have successfully built up the Rxchange<\/a> trading platform in recent years and placed it on the market. In this regard, the platform, the connected infrastructure, and all platform participants have become an important building block in our business and we look forward to expanding this further in the future.”<\/p>\n<\/div><\/div><\/span><\/blockquote>

\"joerg<\/span>Dr. J\u00f6rg Knizek<\/strong>, <\/span>Managing Director of arex PHARMA GmbH<\/span><\/span><\/div><\/div><\/div><\/div><\/div><\/div>

Challenge<\/h2>\n<\/div><\/div><\/div>

The aim was to build a platform on which EU-wide, legally compliant trade in pharmaceutical and medical technology products is possible for all market participants (e.g. wholesalers and intermediaries, importers, clinics, pharmacies, …) with the appropriate licenses, which was previously almost not digitally mapped.<\/p>\n

A particular challenge was to meet all the individually different requirements necessary for the industry, such as batch and expiry management, export restrictions, specifications of the Anti-Counterfeiting Directive, exchange rate fluctuations, etc., while at the same time being able to react quickly to changing market situations.<\/p>\n

All this against the background of making the platform transparent and simple in terms of daily work, also to keep entry barriers for new users\/customers as low as possible.<\/p>\n<\/div>